E. Bridget Kim, PharmD, BCPS, BCOP

Friday, 22 June 2018

Sign Up Now!

To sign up for our newsletter or print publications, please enter your contact information below.

First Name *

Last Name *

Email Address *

Email Address (Verify) *

JHOP Print Edition

We will request your mailing address on the next page.

JHOP/TOP E-Newsletters & Communications

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

Home
Issues
Media Library
- Video Library
- Audiocast Library
CE
Special Issues
- Supplements
- Guide to New FDA Approvals
  2018 Third Annual Guide
  2017 Second Annual Guide
  2016 First Annual Guide
For Authors
Resources
- In the News
- Press Releases
- Web Exclusives
- Online First
- Conference Correspondent
  ASHP 2016 - Oncology
About Us

E. Bridget Kim, PharmD, BCPS, BCOP

Clinical Pharmacist
Ambulatory Oncology
Massachusetts General Hospital
Boston, MA

Authored Items

Evaluation of the Role of Clinical Pharmacists in the Review and Approval of Off-Label Oncology Treatment Requests

Mark L. Zangardi, PharmD, BCOP, E. Bridget Kim, PharmD, BCPS, BCOP, Gayle C. Blouin, PharmD, BCOP

JHOP - June 2018 Vol 8, No 2 in Original Research

Last modified: June 12, 2018

Privacy Policy
Terms of Use

Home
About
Subscribe
Advertise
Contact Us

The Journal of Hematology Oncology Pharmacy^TM | ISSN 2164-1153 (print); ISSN 2164-1161 (online)
©2018 Green Hill Healthcare Communications, LLC, an affiliate of The Lynx Group. All rights reserved.
1249 South River Road - Suite 202, Cranbury, NJ 08512

Home
Issues
Media Library
- Video Library
- Audiocast Library
CE
Special Issues
- Supplements
- Guide to New FDA Approvals
For Authors
Resources
About Us